Peptide record

TPDB03113

Antibacterial Anticancer Toxicity standard
19 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB03113
Antibacterial Anticancer Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia
standard
No
A 19-aa standard-residue multi-activity (Antibacterial, Anticancer, and Toxicity) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
CVKVRVKVGSGVKVRVKVC
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C89H167N29O21S2
ANDEQHILMFPTWY
V
2043.61
10.97
6
0
8
+6
0.98
0.653
122.11
Mammalian: 1.2 hour Yeast: >20 hour E.coli: >10 hour
125
0.06
3
Residue Composition
number
0
A
2
R
0
N
0
D
2
C
0
E
0
Q
2
G
0
H
0
I
0
L
4
K
0
M
0
F
0
P
1
S
0
T
0
W
0
Y
8
V
Amino Acid Distribution
A: 0 R: 2 N: 0 D: 0 C: 2 E: 0 Q: 0 G: 2 H: 0 I: 0 L: 0 K: 4 M: 0 F: 0 P: 0 S: 1 T: 0 W: 0 Y: 0 V: 8
Chemical Descriptors
19 reviewed residue count
C89H167N29O21S2 sequence-only estimate (linear, free termini)
2043.61 sequence-only estimate (linear, free termini)
10.97 sequence-only estimate (linear, free termini)
+6 sequence-only estimate (linear, free termini)
0.98 sequence-only estimate (linear, free termini)
0.653 sequence-only estimate (linear, free termini)
Evidence Records 2 records
Evidence 1 Activity

Activity

50% Hemolysis
Toxicity
590 µM
Hemolytic Cytotoxic
50% Hemolysis | 590 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
De novo design of potent antimicrobial peptides | Antimicrob Agents Chemother | 2004
Evidence 2 Activity

Activity

EC50
Toxicity
590000 nM
Hemolytic
Hemolytic_activity: [Ref.15328096]EC50=590000 nM against human erythrocytes

Target

erythrocytes

Source & Reference

NA
DRAMP
Antimicrob Agents Chemother. 2004 Sep 48(9):3349-3357.